Research database. The Mantel-Haenszel chisquared test for trend was used to assess changes in incidence over time. A 2-sided P value \.05 was considered statistically significant.
by the Wide-Ranging Online Data for Epidemiologic Research database. The Mantel-Haenszel chisquared test for trend was used to assess changes in incidence over time. A 2-sided P value \.05 was considered statistically significant.
From 2010 through 2014, there were 6143 (95% confidence interval [CI] 5810-6495) in-patient admissions for SSSS in the United States, and these admissions occurred most commonly in the summer and fall seasons ( Table I ). The cumulative incidence of SSSS was 7.50 (95% CI 6.78-8.27) per 100,000 population among infants \1 year old, 0.94 (95% CI 0.89-0.99) per 100,000 population among children 1-17 years old, and 0.11 (95% CI 0.10-0.13) per 100,000 population among adults, for an overall incidence of 0.39 (95% CI 0.37-0.41) per 100,000 population. During the study period, the overall incidence of SSSS increased by 47.1% (P trend \ .001). When analyzed by age group, the annual incidence increased by 81.0% (P trend \ .001) among children \1 year old and by 83.8% (P trend \ .001) among children 1-17 years old; however, the annual incidence decreased by 15.4% (P trend \ .001) among adults. In regards to race and ethnicity, the annual incidence of SSSS increased by 188% (P trend \ .001) among blacks and by 51.9% (P trend \ .001) among whites. Incidence data is depicted in Table II. In-hospital mortality from SSSS was 1.3% (95% CI 0.78%-2.1%) for all age categories, 0.31% (95% CI 0.01-0.9%) among patients #17 years old, and 4.3% (95% CI 2.5%-7.3%) among adults. This study might underestimate the incidence and overestimate mortality because patients treated for SSSS in an out-patient setting were absent from this analysis. The incidence calculated here (0.39 per 100,000 persons), though, is higher than previous estimates (0.009 to 0.056 cases per 100,000 persons), which have been limited by small sample sizes (14 cases) and methodological differences (inclusion of bullous impetigo in SSSS incidence calculations). 2, 3 Additional research is necessary to determine if exfoliative toxin-producing strains of S. aureus are becoming more common in certain communities, or if global warming is contributing to the rising incidence of SSSS, considering the condition occurs most often in the warmest months of the year. 
Socioeconomic and geographic barriers to dermatology care in urban and rural US populations
To the Editor: Access to dermatology care is affected by socioeconomic status, rurality, and provider distribution. Patients in higher socioeconomic settings have preferential access and greater use of specialist services.
1 Less than 10% of dermatologists practice in rural areas; 40% practice in the 100 densest US areas. 1 This maldistribution may cause patients to postpone or forgo specialty care, leading to treatment delays and disease progression. Through examining associations between geographic and sociodemographic barriers to care, interventions can be developed to minimize provider maldistribution.
County-specific information regarding provider distribution, geospatial, socioeconomic, and race-specific variables was obtained from the American Academy of Dermatology and US Census Bureau. Variables were compared via t test between counties 1) with versus without dermatologists and 2) with dermatologist: population ratios $3.5 and \3.5 per 100,000 people (Table I) . Geospatial information was represented using CARTO software (available at: carto.com; Fig 1) .
In reviewing provider distribution by county, we found that the mean US dermatologist:population ratio is 1.10 per 100,000 people. Thirty percent has at least 1 dermatologist; 12% have dermatologist: population ratios $3.5 per 100,000 people.
Using geospatial variables, we found that the mean dermatologist:population ratio of rural counties is 423 per 100,000 people; 88% have zero dermatologists. Similar trends exist in otolaryngology, oncology, and cardiology. [2] [3] [4] Using socioeconomic variables, we found that counties with dermatologists have significantly greater median income levels ($53,201) versus counties without dermatologists ($44,443; P \ .05). Similar associations exist in cardiology and radiationoncology.
3,4 A trend exists (r 2 ¼ .970) between county median income versus dermatologist:population ratio.
With regard to race-specific variables, most counties with African American, Hispanic American, and Native American majorities have zero dermatologists. Similarly, neurologists are less likely to practice in areas with higher Latin American and African American populations. 5 Ninety-seven percent (n ¼ 903) of counties with $1 dermatologist have white majorities. Limitations include the fact that roughly 90% of US allopathic dermatologists are members of the American Academy of Dermatology; our results may underestimate provider counts. Our ideal dermatologist:population ratio of 3.5 per 100,000 people is somewhat arbitrary, given that an appropriate ratio has never been validated.
Patients in rural, poor, and high-minority areas lack an acceptable level of access to dermatologists. Minority physicians are more likely to care for patients of their own race and practice in underserved areas. Sadly, only 3% and 4.1% of US dermatologists are African American and Latin American, respectively. Physicians with rural backgrounds and clinical experience are more likely to practice in those areas, as evidenced by Michigan State University's Rural Physician Program. 2, 3 Initiatives to train more dermatologists from rural, poor, or high-minority areas, and methods to incentivize practice in these areas, such as loan forgiveness, should be considered.
The AccessDerm teledermatology initiative has expanded access to dermatologic care by helping patients unable to receive in-person consultation. However, teledermatology alone without access to definitive treatments, including obtaining biopsy specimens, surgical services, and medication monitoring, will not adequately serve the needs of these populations. In addition, dermatologists often serve as advocates in their communities for skin health education. Residency-trained dermatologists are leaders of important public health initiatives when they are active participants in the communities they serve. Excision can be definitive, but these lymphomas have a strong propensity for local recurrence, making field therapy preferable. Locoregional radiation therapy (RT) is an alluring option with significantly higher complete remission rates. 4, 5 Current barriers to referral for RT include the number of treatments needed (12-20) and side effects of standard dose RT (SD-RT). The National Comprehensive Cancer Network recommends 24 to 40 Gy for the treatment of pcBCL (www.nccn.org/ about/nhl.pdf). Although effective, SD-RT is associated with dose-dependent cutaneous side effects, including erythema, desquamation, ulceration, and alopecia. While the latter grade 3 toxicities are quite rare even at the highest recommended radiation doses, very low-dose RT (VLD-RT; 2 Gy 3 2 treatments) is an attractive alternative currently used in the treatment of indolent nodal non-Hodgkin's lymphoma that can also be applied to cutaneous disease.
In this retrospective study, we compared the efficacy of VLD-RT to SD-RT for treatment of pcBCLs. A total of 54 patients with 98 lesions of pcBCL were identified (31 with primary cutaneous
